Published: 2022-03-25

Study of patients with liver dysfunction during pregnancy and their maternal and perinatal outcomes

Kavisha Hablani, Poonam Goel, Navneet Takkar, Dilpreet Kaur Pandher, Jasbinder Kaur, Krishma Thakur


Background: Liver dysfunction in pregnancy can be associated with maternal and perinatal morbidity and mortality, therefore early recognition and timely management is of paramount importance to improve the outcome. The studies related to liver dysfunction in pregnancy and its outcome are sparse from this part of India and are retrospective in nature, so present study was planned.

Methods: A total of 80 pregnant patients with liver dysfunction were enrolled as per the inclusion criteria after taking informed consent. Patients were investigated depending on the symptoms and pregnancy related complications with an aim to know the probable cause of liver dysfunction. Maternal and perinatal outcomes were noted in these patients.

Results: Intrahepatic cholestasis of pregnancy was the most common cause of deranged liver function tests (71.3%) followed by HELLP syndrome (21.3%), viral hepatitis (6.3%) and AFLP (1.3%) respectively. The most common maternal complication seen was preterm labour (33.8%) followed by thrombocytopenia (11.3%), postpartum hemorrhage (7.5%), vaginal wall hematoma (7.5%) and coagulopathy (3.8%). 2 patients (2.5%) required ICU admission and both patients expired due to fulminant hepatic failure. The most common fetal complication was prematurity (33.8%). Intrauterine fetal demise occurred in 10% of the patients and there were 12.5% perinatal deaths observed in our study.

Conclusions: The commonest cause of liver dysfunction in our study was IHCP (71.3%) followed by HELLP syndrome (21.3%). In spite of multidisciplinary approach, liver dysfunction during pregnancy was associated with high maternal and perinatal morbidity and mortality.


Pregnancy, Liver dysfunction, Intrahepatic cholestasis of pregnancy

Full Text:



Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet. 2010;375:594-605.

Tran TT, Ahn J, Reau NS. ACG clinical guideline: Liver Disease and Pregnancy. The Am J Gastroenterol. 2016;111:176-94.

Sumangali PK, Kurian S. Study of abnormal liver function tests in pregnancy in tertiary centre in north Kerala. Int J Res Med Sci. 2017;5:5193-6.

Dsouza AS, Gupta G, Katumalla FS, Goyal S. Maternal and fetal outcome in liver diseases of pregnancy: a tertiary hospital experience. International Journal of Scientific and Research Publications. 2015;5:1-4.

García-Romero CS, Guzman C, Cervantes A, Cerbón M. Liver disease in pregnancy: Medical aspects and their implications for mother and child. Ann Hepatol. 2019;18:553–62.

Karegoudar D, Dhirubhai PR, Dhital M, Amgain K. A study of liver disorder and its consequences in pregnant women with jaundice in a tertiary care centre in Belgaum, Karnataka, India. IOSR Journal of Dental and Medical Sciences. 2014;13:14-18.

Rathi M, Bapat P, Rathi P. Abraham, Effect of liver disease in maternal and foetal outcome-A prospective study. Indian J Gastroenterol. 2007;26:61-63

Dang A, Agarwal N, Bathla S, Sharma N, Balani S. Prevalence of liver disease in pregnancy and its outcome with emphasis on obstetric cholestasis: An Indian scenario. J Obstet Gynaecol. 2010;60:413-8.

Tiwari A, Aditya V, Srivastava R, Gupta G. A study of spectrum and outcome of liver diseases in pregnant women at BRD medical college. Int J Reprod Contracept Obstet Gynecol. 2017;6:3641.